Roivant Sciences Ltd (ROIV)
Net profit margin
Mar 31, 2025 | Mar 31, 2024 | Mar 31, 2023 | Mar 31, 2022 | Mar 31, 2021 | ||
---|---|---|---|---|---|---|
Net income | US$ in thousands | -171,981 | 4,348,930 | -1,009,030 | -845,262 | -809,234 |
Revenue | US$ in thousands | 29,053 | 124,795 | 61,280 | 55,286 | 23,795 |
Net profit margin | -591.96% | 3,484.86% | -1,646.59% | -1,528.89% | -3,400.86% |
March 31, 2025 calculation
Net profit margin = Net income ÷ Revenue
= $-171,981K ÷ $29,053K
= -591.96%
Based on the data provided, the net profit margin of Roivant Sciences Ltd has fluctuated significantly over the years.
As of March 31, 2021, the net profit margin was recorded at -3,400.86%, indicating a substantial loss relative to revenues. The company experienced some improvement in profitability in the following year, with a net profit margin of -1,528.89% as of March 31, 2022. Despite this slight improvement, the company continued to operate at a loss.
In the subsequent year, as of March 31, 2023, the net profit margin further decreased to -1,646.59%, suggesting ongoing challenges in generating profits from its operations. However, there was a significant turnaround in the financial performance of Roivant Sciences Ltd by March 31, 2024, as indicated by a net profit margin of 3,484.86%. This substantial increase in profitability reflects a successful period for the company in terms of generating profits relative to its revenues.
Unfortunately, the data for March 31, 2025, is unavailable (indicated by "—"), making it difficult to provide a complete analysis of the latest financial performance. Nonetheless, the turnaround in profitability in 2024 indicates potential positive developments for Roivant Sciences Ltd.
Overall, the fluctuations in the net profit margin of Roivant Sciences Ltd highlight the importance of closely monitoring financial performance and implementing strategies to improve profitability and sustainable growth in the future.
Peer comparison
Mar 31, 2025